Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

The American Cancer Society is calling on the Trump administration to restore access to comprehensive scientific data.

Grants from the National Institutes of Health come with additional money for overhead. A planned $4 billion cut would leave ...

Blue Ridge Beef’s Natural Mix has been recalled across eight states including Virginia, North Carolina, New York and Maryland ...

The Trump administration recently removed heath data from government websites, which spurred a federal lawsuit filed Tuesday ...

What foods and drinks look like — the colors we see before the first morsels or sips hit our tastebuds — have mattered to ...

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Now that the U.S. Food and Drug Administration has banned Red Dye No. 3, artificial food dyes are under increasing scrutiny.

Recently, the Government Accountability Office issued a report calling for a unified food safety strategy. There aren’t too ...